S. Borrego-Ecija Et Al. , "Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity," ALZHEIMERS & DEMENTIA , vol.20, no.3, pp.1515-1526, 2024
Borrego-Ecija, S. Et Al. 2024. Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity. ALZHEIMERS & DEMENTIA , vol.20, no.3 , 1515-1526.
Borrego-Ecija, S., Perez-Millan, A., Antonell, A., Fort-Aznar, L., KAYA TİLKİ, E., Leon-Halcon, A., ... Llado, A.(2024). Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity. ALZHEIMERS & DEMENTIA , vol.20, no.3, 1515-1526.
Borrego-Ecija, Sergi Et Al. "Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity," ALZHEIMERS & DEMENTIA , vol.20, no.3, 1515-1526, 2024
Borrego-Ecija, Sergi Et Al. "Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity." ALZHEIMERS & DEMENTIA , vol.20, no.3, pp.1515-1526, 2024
Borrego-Ecija, S. Et Al. (2024) . "Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity." ALZHEIMERS & DEMENTIA , vol.20, no.3, pp.1515-1526.
@article{article, author={Sergi Borrego-Ecija Et Al. }, title={Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity}, journal={ALZHEIMERS & DEMENTIA}, year=2024, pages={1515-1526} }